Hepatitis C Virus and Human Immunodeficiency Virus Coinfection Among Attendants of Voluntary Counseling and Testing Centre and HIV Follow Up Clinics in Mekelle Hospital

Overview

Journal Pan Afr Med J

Date 2013 May 30

PMID 23717721

Citations 13

Authors

Haftom Hadush

Solomon Gebre-Selassie

Adane Mihret

Affiliations

Soon will be listed here.

Abstract

Introduction: Hepatitis C virus remains a large health care burden to the world. HIV and HCV coinfection is major global health concern worldwide. However, there is limited information on the prevalence of HCV/HIV co-infection in Ethiopia. The aim of the study was to assess the magnitude of HIV/HCV coinfection and the potential risk factors in attendants of voluntary counseling and testing centre and HIV follow up clinics of Mekelle hospital.

Methods: A cross sectional seroprevalence survey of HCV infection was carried out on 300 HIV negative and positive subjects attending voluntary counseling and testing (VCT) center and HIV follow up clinics of Mekelle hospital, Ethiopia from December 2010-February 2011. Serum samples were tested for anti-HCV antibodies using immunochromatographic test.

Results: Of the 300 study participants, 126(42%) were HIV negative and 174(58%) HIV seropositive from VCT and HIV follow up clinics, respectively. The overall anti-HCV prevalence was 18(6.0%). There were no significant differences in HCV seroprevalence among the different categories of age and sex (p> 0.05). Of the 174 persons with HIV, 16 (9.2%) cases had antibodies to HCV, where as among 126 HIV negative subjects 2 (1.58%) were HCV seropositive (p= 0.006, OR= 6.28, 95% CI= 1.42-27.82).

Conclusion: Accordingly, there was a significant difference in sero-positivity of HCV between HIV positive and HIV negative participants. No apparent risk factor that caused HCV infection was inferred from this study.

Citing Articles

Hepatitis B and C viral coinfections and their association with HIV viral load suppression among HIV-1 infected patients on ART at Mekelle hospital, northern Ethiopia.

Teame G, Gebreyesus A, Tsegay E, Gebretsadik M, Adane K AIDS Res Ther. 2022; 19(1):57.

PMID: 36457041 PMC: 9714192. DOI: 10.1186/s12981-022-00479-8.

Seroprevalence of Hepatitis C Viral Infection in Ethiopia: A Systematic Review and Meta-Analysis.

Deress T, Million Y, Belachew T, Jemal M, Girma M ScientificWorldJournal. 2021; 2021:8873389.

PMID: 33897305 PMC: 8052182. DOI: 10.1155/2021/8873389.

Prevalence of sexually transmitted infections among cervical cancer suspected women at University of Gondar Comprehensive Specialized Hospital, North-west Ethiopia.

Abebe M, Eshetie S, Tessema B BMC Infect Dis. 2021; 21(1):378.

PMID: 33888090 PMC: 8063310. DOI: 10.1186/s12879-021-06074-y.

Hepatitis C Virus Infection among HIV-Infected Patients Attending Dessie Referral Hospital, Northeastern Ethiopia.

Gedefie A, Adamu A, Alemayehu E, Kassa Y, Belete M Int J Microbiol. 2021; 2021:6675851.

PMID: 33552160 PMC: 7846398. DOI: 10.1155/2021/6675851.

Prevalence and associated factors of Hepatitis C virus and human immunodeficiency virus infections among voluntary counseling and testing clients attending private health facilities in Bahir Dar city, North West Ethiopia 2014.

Ameha Z, Tadesse S, Assefa A, Tessema B BMC Res Notes. 2019; 12(1):693.

PMID: 31653230 PMC: 6815064. DOI: 10.1186/s13104-019-4727-9.

References

Ayele W, Nokes D, Abebe A, Messele T, Dejene A, Enquselassie F . Higher prevalence of anti-HCV antibodies among HIV-positive compared to HIV-negative inhabitants of Addis Ababa, Ethiopia. J Med Virol. 2002; 68(1):12-7. DOI: 10.1002/jmv.10164. View

Diro E, Alemu S, GYohannes A . Blood safety & prevalence of transfussion transmissible viral infections among donors at the Red Cross Blood Bank in Gondar University Hospital. Ethiop Med J. 2008; 46(1):7-13. View

Verucchi G, Calza L, Manfredi R, Chiodo F . Human immunodeficiency virus and hepatitis C virus coinfection: epidemiology, natural history, therapeutic options and clinical management. Infection. 2004; 32(1):33-46. DOI: 10.1007/s15010-004-3063-7. View

Lauer G, Walker B . Hepatitis C virus infection. N Engl J Med. 2001; 345(1):41-52. DOI: 10.1056/NEJM200107053450107. View

Walusansa V, Kagimu M . Screening for hepatitis C among HIV positive patients at Mulago hospital in Uganda. Afr Health Sci. 2010; 9(3):143-6. PMC: 2887030. View

Alter M . Epidemiology of viral hepatitis and HIV co-infection. J Hepatol. 2005; 44(1 Suppl):S6-9. DOI: 10.1016/j.jhep.2005.11.004. View

Bruno R, Sacchi P, Puoti M, Maiocchi L, Patruno S, Carosi G . Natural history of compensated viral cirrhosis in a cohort of patients with HIV infection. J Acquir Immune Defic Syndr. 2008; 46(3):297-303. DOI: 10.1097/qai.0b013e31814be887. View

Adewole O, Anteyi E, Ajuwon Z, Wada I, Elegba F, Ahmed P . Hepatitis B and C virus co-infection in Nigerian patients with HIV infection. J Infect Dev Ctries. 2009; 3(5):369-75. DOI: 10.3855/jidc.245. View

Chen S, Morgan T . The natural history of hepatitis C virus (HCV) infection. Int J Med Sci. 2006; 3(2):47-52. PMC: 1415841. DOI: 10.7150/ijms.3.47. View

10.

Thomas D, Leoutsakas D, Zabransky T, Suresh Kumar M . Hepatitis C in HIV-infected individuals: cure and control, right now. J Int AIDS Soc. 2011; 14:22. PMC: 3115833. DOI: 10.1186/1758-2652-14-22. View

11.

Amin J, Kaye M, Skidmore S, Pillay D, Cooper D, Dore G . HIV and hepatitis C coinfection within the CAESAR study. HIV Med. 2004; 5(3):174-9. DOI: 10.1111/j.1468-1293.2004.00207.x. View

12.

Agwale S, Tanimoto L, Womack C, Odama L, Leung K, Duey D . Prevalence of HCV coinfection in HIV-infected individuals in Nigeria and characterization of HCV genotypes. J Clin Virol. 2004; 31 Suppl 1:S3-6. DOI: 10.1016/j.jcv.2004.09.001. View

13.

Tessema B, Yismaw G, Kassu A, Amsalu A, Mulu A, Emmrich F . Seroprevalence of HIV, HBV, HCV and syphilis infections among blood donors at Gondar University Teaching Hospital, Northwest Ethiopia: declining trends over a period of five years. BMC Infect Dis. 2010; 10:111. PMC: 2881920. DOI: 10.1186/1471-2334-10-111. View

14.

Richter S . Laboratory assays for diagnosis and management of hepatitis C virus infection. J Clin Microbiol. 2002; 40(12):4407-12. PMC: 154655. DOI: 10.1128/JCM.40.12.4407-4412.2002. View

15.

Onakewhor J, Okonofua F . The prevalence of dual human immunodeficiency virus/hepatitis C virus (HIV/HCV) infection in asymptomatic pregnant women in Benin City, Nigeria. Afr J Reprod Health. 2010; 13(2):97-108. View

16.

Laurent C, Bourgeois A, Mpoudi M, Butel C, Mpoudi-Ngole E, Delaporte E . HIV and hepatitis C virus coinfection, Cameroon. Emerg Infect Dis. 2007; 13(3):514-6. PMC: 2725885. DOI: 10.3201/eid1303.061069. View

17.

Tripathi A, Khanna M, Gupta N, Chandra M . Low prevalence of hepatitis B virus and hepatitis C virus co-infection in patients with human immunodeficiency virus in Northern India. J Assoc Physicians India. 2007; 55:429-31. View

18.

Madhava V, Burgess C, Drucker E . Epidemiology of chronic hepatitis C virus infection in sub-Saharan Africa. Lancet Infect Dis. 2002; 2(5):293-302. DOI: 10.1016/s1473-3099(02)00264-5. View

19.

Murray K, Richardson L, Morishima C, Owens J, Gretch D . Prevalence of hepatitis C virus infection and risk factors in an incarcerated juvenile population: a pilot study. Pediatrics. 2003; 111(1):153-7. DOI: 10.1542/peds.111.1.153. View

20.

Mboto C, Fielder M, Davies-Russell A, Jewell A . Prevalence of HIV-1, HIV-2, hepatitis C and co-infection in The Gambia. West Afr J Med. 2009; 28(1):16-9. DOI: 10.4314/wajm.v28i1.48418. View